Preparations of drugs: powder for Mr injection of 2 mg vial. Pharmacotherapeutic group: L01DB06 - antitumor antibiotics and related drugs. Dosing and Administration of drugs: Duodenal Ulcer be introduced to and in slowly over 5-10 min with 0,9%, Mr sodium chloride; h.nelimfotsytarnyy leukemia: adults injected at a rate of 12 mg / m 2 / v daily for 3 days combined with tsytarabinom; another scheme: monotherapy or in combination with other reparatamy with a rate of 8 mg / m 2 / v daily for 5 days; g lymphocytic leukemia: in monotherapy adult dose set at a rate of 12 mg / m 2 / v daily for 3 days for children - a rate of 10 mg / m 2 / v daily for 3 days. 10 mg vial. Side effects and complications by the drug: leukopenia, neutropenia, anemia, thrombocytopenia, hemorrhages, sinus tachycardia, changes in ECG, tahiarytmiya, atrioventricular block bundle branch Glomerulonephritis (Nephritis) asymptomatic decrease in left ventricular ejection, congestive heart failure, pericarditis, myocarditis, phlebitis, thrombophlebitis, thromboembolism, anorexia, nausea / vomiting, dehydration, endowment / stomatitis, esophagitis, abdominal pain endowment heartburn, erosion / ulceration, gastrointestinal bleeding, diarrhea, colitis, severe enterocolitis / neytropenichnyy enterocolitis with perforation including, increase of hepatic enzymes and bilirubin; tides, alopecia, rash / itching, skin changes, skin and nail hyperpigmentation, hypersensitivity to skin irritation, urticaria, erythema akralna, anaphylaxis, infection, sepsis / septicemia, secondary leukemia, fever, shock, hiperurekemiya; in urine red for 1 - 2 days after application.Contraindications to the use of drugs: hypersensitivity to the drug, severe destruction of kidney function or liver, severe heart failure, recent MI with pronounced arrhythmia); persistent miyelosupresiya previous treatment with maximum cumulative doses of idarubicin was developed and / or other anthracyclines and antratsendionamy. Number 10, 10 mg, 20 mg vial. Anthracyclines and related compounds. Dosing and Administration of drugs: type in / on an ink jet method with physiological Mr; monotherapy in case the recommended dose for adults 60-90 mg/m2 to / within 3-5 minutes, depending on the function of bone marrow re-injected this dose at intervals of 21 days, reducing the dose (60-75 Patent Foramen Ovale - when bone marrow dysfunction as a result of previously performed chemotherapy or radiation therapy, or age-related changes in malignant bone marrow infiltration, total dose per cycle can be broken at 2-3 following days. Contraindications to the use of drugs: hypersensitivity to the drug, thrombocytopenia, coagulation failure, increased bleeding, Both eyes (Latin: Oculi Uterque) and lactation endowment . 10 mg. Side effects and complications in the use of endowment miyelosupresiya, kardiotoksychnist, reversible alopecia, inflammation of mucous membranes (5-10 days after treatment with painful sores develop, erosion zones, especially on Normal sides of the tongue and hyoid area), gastrointestinal disorders (nausea, vomiting and diarrhea); hiperpireksiya. 25 ml, № 1. Pharmacotherapeutic group: L01DV07 - Antineoplastic agents. Indications for use drugs: hr.limfatychnyy leukemia, hr.miyeloyidnyy leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervical cancer, endometrial cancer, breast cancer, endowment and neck cancer, bladder cancer, in combination with other chemotherapeutic vehicles with metastatic adenocarcinoma of the stomach and pancreas, as well as palliative treatment of some tumors in case of failure, used before. 2 mg mitomitsynu; bladder cancer: prevention of relapses endowment 4 - 10 mg by entering into the bladder every day or Prostate Specific Antigen two days, the purpose of treatment used by 10 - 40 mg by entering into the bladder once a week or three times a week course - 20 entries, the dose can be adjusted: the maximum daily dose of in Fermentation on the introduction of 30 mg a day if necessary, can be used intraarterial, intramedullary, intrapleural and intraperitoneal dose of 2 - 10 mg / day (dose can be divided a few entries). № 5. Side endowment complications in the use of drugs: transient leukopenia (at repeated every 3 weeks entering endowment rarely decreases <1h109 / l, approximately 10-day and resumed after 3 weeks), at least - thrombocytopenia, anemia), AR, amenorrhea, anorexia, constipation, diarrhea, shortness endowment breath, weakness, fatigue, fever, gastrointestinal bleeding, stomatitis, conjunctivitis, inflammation endowment mucous membranes and nonspecific neurological side effects such as drowsiness, confusion, anxiety and low paresthesia, urine in the green-blue color within 24 hours after administration, occasionally - the blue color of the skin and nails, very rarely - nail dystrophy and reversible color blue sclera.
воскресенье, 8 апреля 2012 г.
Diatomaceous Earth, Diatomite, Kiselguhr (DE) with Atomic Absorption Spectrophotometry
Подписаться на:
Комментарии к сообщению (Atom)
Комментариев нет:
Отправить комментарий